No abstract available
MeSH terms
-
Allografts
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bleomycin / administration & dosage
-
Carboplatin / administration & dosage
-
Clinical Trials as Topic
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Doxorubicin / analogs & derivatives
-
Epirubicin / administration & dosage
-
Etoposide / administration & dosage
-
Hematopoietic Stem Cell Transplantation*
-
Human T-lymphotropic virus 1
-
Humans
-
Interferon-alpha / administration & dosage
-
Leukemia-Lymphoma, Adult T-Cell / epidemiology
-
Leukemia-Lymphoma, Adult T-Cell / therapy*
-
Leukemia-Lymphoma, Adult T-Cell / virology
-
Methotrexate / administration & dosage
-
Nitrosourea Compounds / administration & dosage
-
Prednisolone / administration & dosage
-
Prednisone / administration & dosage
-
Prognosis
-
Salvage Therapy
-
Vincristine / administration & dosage
-
Vindesine / administration & dosage
-
Zidovudine / administration & dosage
Substances
-
Antibodies, Monoclonal, Humanized
-
Interferon-alpha
-
Nitrosourea Compounds
-
Bleomycin
-
Epirubicin
-
Zidovudine
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
Prednisolone
-
Carboplatin
-
Vindesine
-
Prednisone
-
mogamulizumab
-
Methotrexate
Supplementary concepts
-
CEV protocol
-
CHOP protocol
-
EPOCH protocol
-
LSG15 regimen
-
VAP-cyclo protocol
-
VEPA-B protocol
-
VEPA-M protocol